Skip to main content
logo
Biomark Diagnostics Inc. (FRA:20B)
Germany flag Germany · Delayed Price · Currency is EUR
0.2760
0.00 (0.00%)
At close: Sep 15, 2026

Biomark Diagnostics Ratios and Metrics

Millions EUR. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Market Capitalization
293614171011
Market Cap Growth
38.45%148.17%-15.29%61.96%-7.18%-45.46%
Enterprise Value
303515181212
Last Close Price
0.280.340.140.190.130.14

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PS Ratio
1714.97961.85145.04152.12100.50356.91
PB Ratio
83.48173.7012.85-40.73-13.42-24.67
P/TBV Ratio
83.48173.7012.85---

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/Sales Ratio
-952.24154.52161.35110.73393.16

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
2.234.290.64-2.54-1.44-3.09
Net Debt / Equity Ratio
0.851.24-0.78-2.28-1.37-2.49
Net Debt / EBITDA Ratio
-0.28-0.240.67-0.82-0.86-1.24
Net Debt / FCF Ratio
-0.45-0.371.24-1.41-1.72-1.25
Asset Turnover
0.010.020.070.180.140.04
Quick Ratio
1.260.972.140.160.060.31
Current Ratio
1.290.992.140.160.080.33
Return on Equity (ROE)
-149.87%-142.59%-340.70%---
Return on Assets (ROA)
-45.63%-43.06%-60.59%-117.29%-104.38%-66.20%
Return on Capital Employed (ROCE)
-117.50%-225.70%-107.60%1099.30%197.40%4328.70%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
-2.99%-2.57%-8.62%-5.75%-11.94%-9.27%
FCF Yield
-2.24%-1.90%-4.90%-3.98%-5.96%-8.06%
Buyback Yield / Dilution
-11.57%-15.58%-6.67%-2.97%-6.22%-6.31%